JNCI-Journal of the National Cancer Institute

Article	Citations
Correction to: ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications	264
Vertical integration in oncology: what does it mean for patients with cancer?	190
Re: Deng and Heybati	147
Response to Liu and Zhang	140
Factors associated with timely COVID-19 vaccination in a population-based cohort of patients with cancer	114
Evaluating a blood test for colon cancer screening: how simulation modeling can inform clinical policy making and research	95
Pre- and post-diagnostic use of antihypertensive medications and stage I-III colorectal cancer survival: prospective cohort study	92
Independent associations between obesity, glucose metabolism, and breast cancer risk through unrelated pathways	88
Discovering plasma proteins associated with breast cancer incidence in postmenopausal women in the Atherosclerosis Risk in Communities study	85
Mediators of Racial Disparities in Heart Dose Among Whole Breast Radiotherapy Patients	79
RE: Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers	78
The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment	76
Method of primary breast cancer detection and the disease-free interval, adjusting for lead time	74
RE: Use of artificial intelligence for cancer clinical trial enrollment	73
Rare cancers research: current state of knowledge and emerging opportunities for prevention and interception	72
The impact of HIV on cervical cancer elimination in KwaZulu-Natal: a comparative modeling analysis	68
Addressing Diversity, Equity, and Inclusion at the JNCI Journals	67
Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer	67
Understanding risk factors for endometrial cancer in young women	63
Dyslipidemia and cardiovascular disease among childhood cancer survivors: a St. Jude Lifetime Cohort report	62
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial	59
Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination	56
Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study	56
Re: Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma	54
The National Cancer Policy Forum: a strong voice for improving cancer care and outcomes	54

Ethylene oxide emissions and incident breast cancer and non-Hodgkin lymphoma in a US cohort	53
Cancer prevention in context: interplay of perceived discrimination, neighborhood deprivation, and cancer-related risk and protective factors	52
Association between smoking habits and breast density, changes in breast density, and breast cancer in Asian women	52
Circulating pre-diagnostic metabolites and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a population-based study of 12 cohorts	52
Long-term aspirin use and cancer risk: a 20-year cohort study	52
Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020	51
Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities	50
Joint associations of accelerometer-measured physical activity and cardiovascular-kidney-metabolic syndrome stages with the risks of cancer and all-cause mortality	50
Association of common genetic alterations with tumor recurrence in papillary thyroid cancer	49
Reduced adipose tissue with limited loss of lean mass after weight loss: results from the Prostate Cancer Active Lifestyle Study	49
RE: Prevalence of cancer survivors in the United States	49
RE: Autoimmune disease and the risk of anal cancer in the US elderly population	48
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line col	47
Correction to: Obesity-Specific Improvement of Lung Cancer Outcomes and Immunotherapy Efficacy with Metformin	46
Cancer control co-benefits of the climate-related provisions in the American Inflation Reduction Act	46
Correction to: Quality of Life in Older Adults After Major Cancer Surgery: The GOSAFE International Study	45
Treatment deescalation for older women with favorable breast cancers: patient values and shared decision making	44
Landscape of somatic genetic alterations and PAM50 intrinsic subtypes in breast cancer associated with germline pathogenic variants in DNA-repair genes	42
Toxicity risk score and clinical decline after adjuvant chemotherapy in older breast cancer survivors	42
Association between racialized economic segregation and stage at diagnosis for 3 screenable cancers in New York City	42
The triple effect of colorectal cancer screening: reducing deaths, government spending, and mortality disparities	41
Redefining rurality: adopting an identity-based and community-engaged approach to defining rural cancer disparities	40
Response to Omoleye, Esserman, Olufunmilayo	40
Neurocognitive impairment and financial hardship in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study	40
Premature aging as an accumulation of deficits in young adult survivors of pediatric cancer	40
Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study	39
Evaluating colonoscopy quality by performing provider type	39
Brain metastases among older people with cancer	39
Stat Bite: Prevalence of cancer in the United States in 2022	38
Determinants of late metastases in renal cell carcinoma	38
US Food and Drug Administration approvals for pediatric cancer indications using Children’s Oncology Group–associated trials data	38
Molecular and clinical insights of trastuzumab deruxtecan efficacy in advanced breast cancer	37
Exposure to polycyclic aromatic hydrocarbons, volatile organic compounds, and tobacco-specific nitrosamines and incidence of esophageal cancer	37
Impact of knowledge of human papillomavirus positivity on cervical cytology performance in Latin America	36
Optimizing public-private partnerships to support clinical cancer research	36
Urgent need to mitigate disparities in federal funding for cancer research	36
Contribution of health insurance to racial and ethnic disparities in advanced-stage diagnosis of 10 cancers	36
Patients’ attitudes and preferences toward delayed disease progression in the absence of improved survival	36
Putting patients first to redefine prostate cancer classifications	36
Design-Outcome Concordance in Targeted-Therapy trials in Non-Small cell lung cancer: a Meta-Research study	35
The National Health Service–Galleri multicancer screening trial: explanation and justification of unique and important design issues	35
Utility of recurrence-based surrogate endpoints for survival in adjuvant cancer trials: evidence from melanoma	35
Epidemiology of early vs late recurrence among women with early stage estrogen receptor–positive breast cancer in the Pathways Study	34
Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome	34
Dietary interventions in cancer: a systematic review of all randomized controlled trials	34
Response to Wang et al. and Shen et al.	34
Leisure-time physical activity after diagnosis and survival by cancer type: a pooled analysis	33
Editor’s Note on: Hypoxia-inducible Factor 1α and Antiangiogenic Activity of Farnesyltransferase Inhibitor SCH66336 in Human Aerodigestive Tract Cancer	33
Response to Shen	33
Age-standardised (world) incidence rates of the 33 leading cancers in the U.S., the European Union (EU-27), Sub-Saharan Africa, and China in 2022, all ages, both sexes combined	33

Health-related quality of life by race, ethnicity, and country of origin among cancer survivors	33
Response of bilateral Wilms tumor to chemotherapy suggests histologic subtype and guides treatment	33
Engineered allogeneic stem cells orchestrate T lymphocyte–driven immunotherapy in immunosuppressive leptomeningeal brain metastasis	32
The decision aid is the easy part: workflow challenges of shared decision making in cancer care	32
Ambient ultraviolet A, ultraviolet B, and risk of melanoma in a nationwide United States cohort, 1984-2014	32
Maternal serum concentrations of per- and polyfluoroalkyl substances and childhood acute lymphoblastic leukemia	31
Physical activity and checkpoint inhibition: association with toxicity and survival	31
Social vulnerability and survival in 112 000 adolescents and young adults with cancer: a population-based study	30
RE: Heterozygous BRCA1/BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer	30
Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patients	30
Breast cancer recurrence and mortality among survivors of childhood cancer	29
Addressing conceptual and design gaps in the oncology nutrition evidence base during chemotherapy: contributions of the Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcome	29
Association of N-terminal pro–brain natriuretic peptide with survival among US cancer survivors	29
Correction to: The association of where patients with prostate cancer live and receive care on racial treatment inequities	29
HPV vaccine impact: genotype-specific changes in cervical pre-cancer share similarities with changes in cervical screening cytology	28
Smoking as a prognostic factor for survival in patients with disseminated germ cell cancer	28
Facility exposure to wildfire disasters and hospital length of stay following lung cancer surgery	28
Can early prostate cancer screening help address mortality disparities among Black men?	28
Intelligent oncology systems begin with connecting the data we already have	27
Protecting vulnerable patient populations from climate hazards: the role of the nation’s cancer centers	27
Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators	27
Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy	27
Prognostic factors in localized pancreatic ductal adenocarcinoma after neoadjuvant therapy and resection: a systematic review and meta-analysis	27
Proportion of patients in phase 2 oncology trials receiving treatments that are ultimately approved	27
Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologies	27
RE: Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer	26
RE: Tamoxifen therapy benefit in luminal A and B breast cancer with 20-year follow-up	26
CRC-SPIN version 3.0: an updated policy model for colorectal cancer screening that includes the serrated pathway	25
Mapping the contributions of adjuvant tamoxifen, 20 years later	25
Assessing racial, ethnic, and nativity disparities in US cancer mortality using a new integrated platform	25
Association between diet quality and ovarian cancer risk and survival	25
Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial	25
Risk of early death in adolescents and young adults with cancer: a population-based study	25
Response to Song	25
The National Cancer Institute’s Cancer Information Service: 50 years of service to the nation	24
Outcomes after solid organ transplantation in survivors of childhood, adolescent, and young adult cancer: a population-based study	24
Response to Semprini and Osazuwa-Peters	24
Change in body mass index and physical activity and postmenopausal breast cancer risk in a cohort of Dutch nurses	24
RE: Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer	24
RE: Informing women about overdetection in breast cancer screening: Two-year outcomes from a randomized trial	24
Association of longer telomere length in cancer cells and cancer-associated fibroblasts with worse prognosis	24
Childhood Cancer-Connect: Identifying solutions to elevating the cancer experience for adolescents and young adults with cancer	24
Correction to: Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome	24
Social Determinants of Health and Cancer Care: Where Do We Go From Here?	23
Oncofertility patterns after the overturn of Roe v Wade	23
Centers for Medicare and Medicaid and colorectal cancer screening test standards: time for a change	23
Stat Bite: cumulative risk of cancer incidence up to ages 50 and 75 by sex in 2022	23
Clinician validation of the Medicare measure for potentially avoidable hospital visits after chemotherapies	23
Preexisting evidence and outcome of phase III trials in gastrointestinal oncology: a systematic review	23
Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma	23
Ambient air pollution and mortality in older patients with breast cancer	23
RE: Growth of zero-premium Medicare Advantage plans in counties with high cancer mortality	23
Test performance metrics for breast, cervical, colon, and lung cancer screening: a systematic review	23
Differences in tumor-associated T-cell receptor repertoires between early-onset and average-onset colorectal cancer	22
Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients	22
The use of master protocols for efficient trial design to evaluate radiotherapy interventions: a systematic review	22
Risk of atherosclerotic cardiovascular disease after cancer diagnosis: findings from 3 prospective cohort studies	22
The unique risk factor profile of triple-negative breast cancer: a comprehensive meta-analysis	22
Impact of major depressive disorder on breast cancer outcomes: a national retrospective cohort study	22
Alzheimer disease–related biomarkers and cancer-related cognitive decline: the Thinking and Living with Cancer study	22
Rising incidence of early-onset colorectal cancer: impact of anatomy and histology	22
Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial	22
Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer	21
Genome-wide DNA methylation and transcriptomic patterns of precancerous gastric cardia lesions	21
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer	21
Association between glucagon-like peptidase 1 receptor agonist and obesity-related cancer in overweight or obese patients with type 2 diabetes: a nationwide cohort study	21
Global paid and unpaid productivity losses due to cancer-related mortality	21
Adiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysis	21
Sex-based prognosis in industry-sponsored advanced solid tumor trials: an individual participant data meta-analysis of survival and adverse events	21
Red-flag signs and symptoms for earlier diagnosis of early-onset colorectal cancer	20
Time to change the paradigm for primary endpoints in cancer screening trials?	20
Symptoms and early-onset colorectal cancer: red flags are common flags!	20
The evolving landscape of oropharyngeal cancer: a window of opportunity for primary prevention	20
Correction to: Delta-Like Ligand 4–Notch Blockade and Tumor Radiation Response	20
Editor’s Note: Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1	20
Expression of Concern: Delta-Like Ligand 4–Notch Blockade and Tumor Radiation Response	20
Identification of immune cell type–specific susceptibility genes in multiple cancers using transcriptome-wide association studies	20
Beyond survival: a closer look at lead-time bias and disease-free intervals in mammography screening	20
Characteristics of patient navigation programs in the Cancer Moonshot ACCSIS colorectal cancer screening initiative	19
Re: Incidence of in situ vs invasive melanoma: testing the “obligate precursor” hypothesis	19

Design of randomized controlled trials to estimate cancer-mortality reductions from multicancer detection screening	19
Human papillomavirus–related squamous cell carcinomas after blood or marrow transplantation—a Blood or Marrow Transplant Survivor Study report	19
Comparing characteristics of individuals screened for lung cancer with 2021 vs 2013 US Preventive Services Task Force recommendations	19
Response to Cheng, Palesh, and Hong	19
Prophylactic human papillomavirus vaccination for prevention of oropharyngeal cancer in older men: is the juice worth the squeeze?	19
Response to Shen and Li	19
Opioid tapering in older cancer survivors does not increase psychiatric or drug hospitalization rates	19
Real-world impact of the platinum chemotherapy shortage on US patients with advanced cancer	19
A novel classification of small bowel adenocarcinoma based on the hidden genome classifier: a multi-institutional study	18
Association of differential censoring with survival and suboptimal control arms among oncology clinical trials	18
Evaluation of the flipped dose NIVO3+IPI1 in patients with advanced unresectable melanoma	18
Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer	18
Leveraging national and global political determinants of health to promote equity in cancer care	18
Climate change and cancer: the Environmental Justice perspective	18
Circulating proteome for pulmonary nodule malignancy	18
RE: Advance care planning impact on caregivers and end-of-life care in advanced cancer	18
Adjuvant dual HER2 blockade along the HER2-ER axis in APHINITY	18
Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease	18
A validated estimate of visceral adipose tissue volume in relation to cancer risk	18
Melanoma thickness and long-term mortality	18
Changes in cancer mortality after Medicaid expansion and the role of stage at diagnosis	17
Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohort	17
Correction to: Mortality among patients with diffuse large B-cell lymphoma and mental disorders: a population-based study	17
Correction to: Discovering plasma proteins associated with breast cancer incidence in postmenopausal women in the Atherosclerosis Risk in Communities study	17
Streamlining the conduct of cancer clinical trials: new standard data collection practices for National Cancer Institute late-phase clinical studies	17
Response to Etminan	17
Stat Bite: Variations in nasopharyngeal cancer incidence rates according to registries included in Cancer Incidence in Five Continents, Volume XII	17
Mortality among patients with diffuse large B-cell lymphoma and mental disorders: a population-based study	17
Reducing—a little—the high price of randomized trials of the efficacy of multicancer early detection	17
Tracking community outreach and engagement activities among National Cancer Institute-designated cancer centers	17
The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies	16
Malignant peripheral nerve sheath tumors: a report from Children’s Oncology Group study ARST0332	16
Increasing radiation therapy and lower survival for human papillomavirus–related oropharynx cancer associated with a shift to community cancer center care	16
Lung Cancer Absolute Risk Models for Mortality in an Asian Population using the China Kadoorie Biobank	16
Disparities in cancer incidence by rurality in California	16
Developing the next-generation cancer research workforce in the National Institutes of Health Intramural Research Program	16
Incidence of rare cancers during the COVID-19 pandemic: a US population-based study	16
Trends in the incidence of cancers related to HIV-AIDS in Harare, Zimbabwe 1990-2019	16
Thyroid hormones and epithelial ovarian cancer risk and survival: results from the European Prospective Investigation into Cancer and Nutrition study	16
RE: Pre-diagnosis thyroid dysfunction and ovarian cancer risk and survival: a prospective cohort study	16
Tucatinib promotes immune activation and synergizes with programmed cell death–1 and programmed cell death–ligand 1 inhibition in HER2-positive breast cancer	16
What matters to society when making decisions about reimbursing drugs for prostate cancer: a discrete choice experiment	16
Liver elastography-based risk score for predicting hepatocellular carcinoma risk	15
Platinum ineligibility and survival outcomes in patients with advanced urothelial carcinoma receiving first-line treatment	15
Effect of chronic disease on racial difference in COVID-19–associated hospitalization among cancer patients	15
Response to Khouri and Suissa	15
Impact of racial disparities in follow-up and quality of colonoscopy on colorectal cancer outcomes	15
Genetic risk and likelihood of prostate cancer detection on first biopsy by ancestry	15
RE: The impact of multidisciplinary cancer conferences on overall survival: a meta-analysis	15
Assessment of intermediate-term mortality following pancreatectomy for cancer	15
Integrating oncology advanced practice providers and clinical pharmacists into clinical cancer research	15
Metformin use and risk of colorectal cancer in patients with inflammatory bowel disease: a nationwide, population-based cohort study	15
Response to Sorscher	15
Response to Maltoni, Puccetti, Poli, et al.	15
Frequency and clinical features of germline pathogenic variants in sarcoma: a case-control study	14
Addressing health-related quality of life inequities in cancer: where do we go from here?	14
RE: Electroacupuncture for quality of life during adjuvant chemotherapy in gastric cancer: a randomized trial	14
COVID-19 vaccination, infection, and symptoms among cancer survivors in the United States	14
RE: Prophylactic antiviral therapy and all-cause mortality in cancer patients with hepatitis B e antigen-negative chronic hepatitis B virus infection receiving immunosuppressive therapy	14
Stereotactic magnetic resonance imaging-guided adaptive radiotherapy: a pooled analysis of a master prospective trial	14
Stat Bite: Convergence of long-term trends in cervix uteri cancer incidence among Black and White women from 1975 to 2021	14
Correction to: In memoriam: Pelayo Correa, MD (1927–2025)	14
In Memoriam: Pierre Hainaut (1958-2025)	14
Risk factors for second primary breast cancer by laterality, age, and race and ethnicity	14
Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules	14
Long-term trends in cancer mortality by rural-urban status, United States, 1969-2023	14
Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trial	14
Prostate Cancer Imaging Stewardship: a multimodal, physician-centered intervention for guideline-concordant imaging	14
Neoadjuvant vs perioperative chemo-immunotherapy according to pathological response in resectable non-small cell lung cancer: a reconstructed individual patient data meta-analysis	13
Comparative cost-effectiveness of contemporary treatment strategies for stage IIA seminoma	13
Influence of endoxifen on mammographic density: results from the KARISMA-Tam trial	13
Making human derived data FAIR: feedback from NCI office of data sharing workshop	13
Comparative 10-year performance of mammography artificial intelligence, polygenic, and clinical breast cancer risk models in the Kaiser Permanente Research Bank	13
Prevalence of anal cytology screening among persons with HIV and lack of access to high-resolution anoscopy at HIV care facilities	13
Long-term behavioral symptom clusters among survivors of early-stage breast cancer: Development and validation of a predictive model	13
Response to Xu, Yu, Hu et al	13
Association of human papillomavirus on risk of HIV acquisition in African women: analyses from MTN-020/ASPIRE	13
The risk and benefit profiles of US-eligible lung cancer screening attendees vs nonattendees	13
RE: Social factors influence cancer trial participation: can digital interventions help close the disparities gap?	13
Low physical function following cancer diagnosis is associated with higher mortality risk in postmenopausal women	13
Assessment of Caregivers’ Burden When Caring for Patients With Pancreatic and Periampullary Cancer	13
The association of where patients with prostate cancer live and receive care on racial treatment inequities	13
Inflammatory and insulinemic dietary patterns and risk of endometrial cancer among US women	13
Risk factors for breast cancer subtypes by race and ethnicity: a scoping review	13
The evolution of NCI’s Health Information National Trends Survey: methods, data, and future directions	13
Identifying expression and DNA methylation biomarkers for lung adenocarcinoma risk in East Asia	13
Germline rare variants in cancer susceptibility genes and subsequent neoplasm risk after childhood cancer	13
Development and validation of a risk prediction model for acute care use among older advanced cancer patients on clinical trials	13
Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2	13
Endoscopic screening for colorectal cancer: efficacy versus effectiveness	13
The impact of survivorship care on burden of disease among Hodgkin lymphoma survivors	13
Cancer-associated arterial thromboembolism: real-world burden from a nationwide electronic health record database	13
Trends in colorectal cancer mortality among younger versus older adults in 49 countries	13
Response to Piscitello et al.	12
Climate change mitigation and synergies with primary cancer prevention in Europe: time to implement opportunities	12